A prospective investigation into the effect of colchicine on tuberculous pericarditis

Cardiovascular Journal of Africa

Volumn 27, Issue 6, 2016, Pages 350-355

  Liebenberg, Jurgens Jacobus ^a   Dold, Catherine Jane ^b   Olivier, Lourens Rasmus ^c  

^a Worcester Medi Clinic   (South Africa)

^b Hanover Park Day Hospital   (South Africa)

^c Medi Clinic Hospital   (South Africa)

Author keywords

Colchicine; Constrictive pericarditis; Pericarditis; Tuberculosis

Indexed keywords

COLCHICINE; CORTICOSTEROID; ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SOUTH AFRICA; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOUS PERICARDITIS; COLOR DOPPLER ECHOCARDIOGRAPHY; DIAGNOSTIC IMAGING; HIV INFECTIONS; MICROBIOLOGY; MIXED INFECTION; PERICARDITIS, CONSTRICTIVE; PERICARDITIS, TUBERCULOUS; PULSED DOPPLER ECHOCARDIOGRAPHY; RISK FACTOR; TIME FACTOR;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTITUBERCULAR AGENTS; COINFECTION; COLCHICINE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS, CONSTRICTIVE; PERICARDITIS, TUBERCULOUS; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME;

EID: 85006048995     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2016-035     Document Type: Article

References (19)

1. Global Health Education. TB Facts. tbfacts.org (Accessed 18 August 2015).
2. Maosi B, Burgess L, Doubell A. Heart disease in Africa - tuberculous pericarditis. Circulation 2005; 112: Doi: 10.1161/CIRCULATIOHAHA.105.543066 (assessed 21 August 2015).
3. Syed F, Mayosi B. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 2007; 50(3): 218-236.
4. Mauyaba AK, Balkaran S, Cloete R, et al. Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital, Cape Town, South Africa: Causes and perioperative outcomes in the HIV era (1990- 2012). J Thorac Cardiovasc Surg 2014; 148(6): 3058-3065.
5. Mayosi B, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med 2014; 371(12): 1121-1130.
6. Reuter H, Burgess L, Louw V, Doubell A. The management of tuberculous pericardial effusion: Experience in 233 consecutive patients. Cardiovasc J Afr 2007; 18(1): 20-25.
7. Strang J, Kakaza H, Gibson D, Allen B, Mitchison D, Evans D, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in the treatment of tuberculous pericardial effusion in Transkei. Lancet 1988; 2: 759-764.
8. Tramontana JM, Utaipat U, Molloy A, et al. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995; 1: 384-397.
9. Mann-Segal DD, Shanahan EA, Jones B, Ramasamy D. Purulent pericarditis: Rediscovery of an old remedy. J Thorac Cardiovasc Surg 1996; 111: 487-488.
10. Ekim H, Dermirbag R. Intrapericardial streptokinase for purulent peri carditis. Surg Today 2004; 34: 569-572.
11. Juneja R, Kothari SS, Saxena A, et al. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child 1999; 80: 275-277.
12. Graham W, Roberts JB. Intravenous colchicine in the treatment of gouty arthritis. Ann Rheum Dis 1953; 12(1): 16-19.
13. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis - results of the Colchicine for Acute Pericarditis (COPE) trial. Circulation 2005; 112: 2012-2016.
14. Guidelines: National Tuberculosis Management Guidelines. Health-e. 2015 [online] Available at: Http://www.health-e.org.za/2014/06/10/guidelines- national-tuberculosis-manangement-guidelines/. [Accessed 23 August 2015].
15. Reuter H, Burgess L, van Vuuren W, Doubell A. Diagnosing tuberculous pericarditis. Q J Med 2006; 99(12): 827-839.
16. Dal-Bianco JP, Sengupta PP, Mookadam F, Chandrasekaran K, Tajik AJ, Khandheria BK. Role of echocardiography in the diagnosis of constricitve pericarditis. J Am Soc Echocardiogr 2009; 22(1): 24-33.
17. BSE: A standard transthoracic echo. 2015. [online] Available at: Http://www.bsecho.org/tte-minimum-dataset/[Accessed 23 August 2015].
18. Oh JK, Tajik JT, Christopher PA, Hatle LK, Nishimura RA, Seward JB. Preload reduction to unmask the characteristic Doppler features of constrictive pericarditis. Circulation 1997; 95: 796-799.
19. Boonyaratavej S, Oh JK, Tajik AJ, Appleton CP, Seward JB. Comparison of mitral inflow and superior vena cava Doppler velocities in chronic obstructive pulmonary disease and constrictive pericarditis. J Am Cardiol 1989; 63: 483-488.